AU2002214267A1 - Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient - Google Patents

Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient

Info

Publication number
AU2002214267A1
AU2002214267A1 AU2002214267A AU1426702A AU2002214267A1 AU 2002214267 A1 AU2002214267 A1 AU 2002214267A1 AU 2002214267 A AU2002214267 A AU 2002214267A AU 1426702 A AU1426702 A AU 1426702A AU 2002214267 A1 AU2002214267 A1 AU 2002214267A1
Authority
AU
Australia
Prior art keywords
remedies
active ingredient
diseases containing
farnesyl acetate
keratoconjunctival diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214267A
Inventor
Ken-Ichi Endo
Hajime Ibuki
Mitsuaki Kuwano
Masatsugu Nakamura
Katsuhiko Nakata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of AU2002214267A1 publication Critical patent/AU2002214267A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002214267A 2000-11-08 2001-11-08 Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient Abandoned AU2002214267A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-340115 2000-11-08
JP2000340115 2000-11-08
PCT/JP2001/009760 WO2002038149A1 (en) 2000-11-08 2001-11-08 Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient

Publications (1)

Publication Number Publication Date
AU2002214267A1 true AU2002214267A1 (en) 2002-05-21

Family

ID=18815078

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214267A Abandoned AU2002214267A1 (en) 2000-11-08 2001-11-08 Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient

Country Status (8)

Country Link
US (1) US20040014812A1 (en)
EP (1) EP1338279A1 (en)
KR (1) KR20030048129A (en)
CN (1) CN1228047C (en)
AU (1) AU2002214267A1 (en)
CA (1) CA2428207A1 (en)
NO (1) NO20032035L (en)
WO (1) WO2002038149A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080153908A1 (en) * 2006-12-20 2008-06-26 Jani Dharmendra M Method of Treating Mucin Deficiency with an Active Pharmaceutical and Related Composition
JP5758501B2 (en) * 2012-08-10 2015-08-05 三菱重工業株式会社 Floating wind power generator
JP6760275B2 (en) * 2015-05-12 2020-09-23 ライオン株式会社 Ophthalmic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5573642A (en) * 1978-11-28 1980-06-03 Kuraray Co Ltd Farnesyl-acetic ester derivative
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
US5567729A (en) * 1993-10-28 1996-10-22 David L. Bradfute Farnesyl compounds as farnesyl protein transferase inhibitors to treat ras induced tumor growth
JP3136352B2 (en) * 1996-01-22 2001-02-19 参天製薬株式会社 Keratoconjunctival disease therapeutic agent
JPH10265378A (en) * 1997-03-25 1998-10-06 Ofutekusu:Kk Therapeutic agent for ectocornea injury
US6303654B1 (en) * 1998-03-12 2001-10-16 Wisconsin Alumni Research Foundation Acyclic monoterpenoid derivatives
US6432931B1 (en) * 1998-06-24 2002-08-13 Merck & Co., Inc. Compositions and methods for inhibiting bone resorption

Also Published As

Publication number Publication date
CA2428207A1 (en) 2002-05-16
US20040014812A1 (en) 2004-01-22
EP1338279A1 (en) 2003-08-27
CN1228047C (en) 2005-11-23
NO20032035D0 (en) 2003-05-06
NO20032035L (en) 2003-06-20
KR20030048129A (en) 2003-06-18
WO2002038149A1 (en) 2002-05-16
CN1473039A (en) 2004-02-04

Similar Documents

Publication Publication Date Title
AU2000279625A1 (en) Blood mmp-3 level-lowering agent containing il-6 antgonist as the active ingredient
IL160253A0 (en) Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU2001286221A1 (en) Remedies for ischemic diseases
AU2002234525A1 (en) Transdermal therapeutic system comprising the active ingredient oxybutynin
EP1604971A4 (en) Cinnamyl alcohol derivative compounds and drugs containing the compounds as the active ingredient
AU2001234089A1 (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
AU2000279614A1 (en) Remedies for endothelin-induced diseases
AU2001258395A1 (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
AU6386801A (en) System for the release of active ingredients
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
AU4317500A (en) Antibiral compositions containing phorbol derivatives as the main active ingredient
AU2001241162A1 (en) Remedies for allergic diseases
AU2001278680A1 (en) Erectile dysfunction remedies containing prostaglandin derivatives as the activeingredient
AU2002214267A1 (en) Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient
AU2002328000A1 (en) Use of substances with oxytocin activity for the preparation of a pharmaceutical composition against inflammation
AU2001292301A1 (en) Novel drugs for liver diseases
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
AU2001292578A1 (en) Pharmaceutical compounds
AU2002363776A1 (en) Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
IL161768A0 (en) Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
AU2001228863A1 (en) Remedies for ophthalmic diseases
IL154049A0 (en) Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
WO2002024210A3 (en) Halogen compounds for use in medicine